Presentation and survival of multiple myeloma patients in Ghana: a review of 9 cases

ME Acquah, AW Hsing, V McGuire, S Wang… - Ghana medical …, 2019 - ajol.info
Background: Africans have an increased risk for multiple myeloma (MM) compared to other
races. Reports from Africa are few and involve small cohorts, but suggest significant …

[HTML][HTML] Profil diagnostique et évolutif du myélome multiple au Sénégal: étude monocentrique de 2005 à 2016

S Fall, F Dieng, C Diouf, B Djiba, AC Ndao… - The Pan African …, 2017 - ncbi.nlm.nih.gov
Profil diagnostique et évolutif du myélome multiple au Sénégal: étude monocentrique de 2005
à 2016 - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Diagnostic and evolutionary profile of multiple myeloma in Senegal: monocentric study conducted from 2005 to 2016

S Fall, F Dieng, C Diouf, B Djiba, AC Ndao… - The Pan African …, 2017 - europepmc.org
Methods We conducted a retrospective, descriptive, analytical study (2005-2016) of patients
with myeloma included in the study based on International Myeloma Working Group (IMWG) …

Electrophoretic Profile of Multiple Myeloma at the Biochemistry Laboratory of Dalal Jamm National Hospital

A Samba, S Thiam, IY Soumah, F Diedhiou… - Advances in Biological …, 2024 - scirp.org
Introduction: Multiple myeloma (MM) is characterized by the abnormal proliferation of a
plasma cell clone invading the bone marrow, with secretion of a monoclonal …

[HTML][HTML] Parcours préhospitalier du patient ayant un myélome multiple à Brazzaville

L Ngolet, I Kocko, FOAT Galiba… - Health Sciences and …, 2016 - hsd-fmsb.org
Objectif: Le diagnostic du myélome multiple se fait à un stade tardif en Afrique. Les raisons
du retard diagnostique nécessitent d'être rapportées. Matériels et méthodes: Une enquête …

[PDF][PDF] Gammapathies monoclonales maliGnes (myelome multiple et MacroglobulineMie de WaldenströM): Aspects epidemiologiques, cliniques et biologiques des …

A BELLOUCH - 2021 - toubkal.imist.ma
Docteur en Pharmacie Page 1 Année: 2021 Thèse N: 50 Gammapathies monoclonales
maliGnes (myelome multiple et MacroglobulineMie de WaldenströM) : Aspects …

[PDF][PDF] Predictive factors of therapeutic response in multiple myeloma in the Cameroonian subject: A multicentric study in Yaoundé

CC Bernard, DMP Bertille, T Claude… - The Journal of …, 2018 - researchgate.net
Background: There is lack of data on clinical, epidemiological and therapeutic factors that
influence optimal clinical response in patients treated for multiple myeloma in Cameroon …

Epidemiological, clinical, biological, and prognostic presentation of multiple myeloma in Casablanca (Morocco)

N Gaougaou, L Bahri, A Quessar… - Journal Africain du …, 2014 - Springer
Résumé Le but de notre étude est de décrire les particularités épidémiologiques, cliniques,
biologiques et pronostiques du myélome multiple (MM). Il s' agit d'une étude prospective …

Cyclophosphamide, Thalidomide and Dexamethasone (CTD) as First-Line Therapy in Multiple Myeloma Patients: An Experience in a Clinical Haematology Centre in …

EHD Niang, S Fall, K Sarr, ML Camara… - Open Journal of …, 2023 - publish7promo.com
Introduction: Induction therapy followed by high-dose chemotherapy with autologous stem
cell transplantation remains the gold standard for myeloma patients who can tolerate this …

Compressive Myeloradiculopathies in Multiple Myeloma: Clinical and Radiological Characteristics of a Series of 29 Patients

EHD Niang, MA Bamba, K Mamadou… - Open Journal of …, 2021 - publish7promo.com
Introduction: Patients with multiple myeloma (MM) develop neurological complications such
as root and/or spinal cord compression in at least 5% of cases. The aim of this work is to …